Celestica: Why I'm Buying This Stock

Nikada Investment Thesis Celestica (NYSE:CLS) delivered Q4 results that were slightly better than I expected. But as I've stated throughout, as an inflection investor, it's much more important to understand and gauge what investors are pricing in, rather than simply picking out high-growth stocks. That being said, I am pleasantly surprised by the strength of Celestica's Q1 2024 outlook. Even though management has not put out particularly bullish guidance for 2024, I believe that management is simply being p ...